Nucleic Acid-Guided Nucleases (2017)

Manus Inscripta, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 15/631,989, filed Jun 23, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 10,011,849	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Term ends Jun 23, 2037 · High confidence	Manus Inscripta, Inc.	In force	Term ends Jun 23, 2037	Term ends Jun 23, 2037	High confidence
US 10,435,714	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Term ends Jun 23, 2037 · High confidence	Manus Inscripta, Inc.	In force	Term ends Jun 23, 2037	Term ends Jun 23, 2037	High confidence
US 10,626,416	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Term ends Jun 23, 2037 · High confidence	Manus Inscripta, Inc.	In force	Term ends Jun 23, 2037	Term ends Jun 23, 2037	High confidence
US 11,130,970	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Term ends Jun 23, 2037 · High confidence	Manus Inscripta, Inc.	In force	Term ends Jun 23, 2037	Term ends Jun 23, 2037	High confidence
US 11,220,697	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Term ends Jun 23, 2037 · High confidence	Manus Inscripta, Inc.	In force	Term ends Jun 23, 2037	Term ends Jun 23, 2037	High confidence
US 11,306,327	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Term ends Jun 23, 2037 · High confidence	Manus Inscripta, Inc.	In force	Term ends Jun 23, 2037	Term ends Jun 23, 2037	High confidence
US 12,195,749	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Ends no later than Jun 30, 2037 · Medium confidence	Manus Inscripta, Inc.	In force	Ends no later than Jun 30, 2037	Ends no later than Jun 30, 2037	Medium confidence
Application 18/945,973	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. Pending Not granted	Manus Inscripta, Inc.	Pending	Not granted	not computed

8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

7 of these are in force and held by Manus Inscripta, Inc..

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.